Your browser doesn't support javascript.
loading
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies.
Tan, Antoinette R; Chan, Nancy; Kiesel, Brian F; Stein, Mark N; Moss, Rebecca A; Malhotra, Jyoti; Aisner, Joseph; Shah, Mansi; Gounder, Murugesan; Lin, Hongxia; Kane, Michael P; Lin, Yong; Ji, Jiuping; Chen, Alice; Beumer, Jan H; Mehnert, Janice M.
Afiliação
  • Tan AR; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. Antoinette.Tan@atriumhealth.org.
  • Chan N; Atrium Health, Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USA. Antoinette.Tan@atriumhealth.org.
  • Kiesel BF; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Stein MN; University of Pittsburgh, Pittsburgh, PA, USA.
  • Moss RA; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Malhotra J; Columbia University Medical Center, New York, NY, USA.
  • Aisner J; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Shah M; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
  • Gounder M; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Lin H; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Kane MP; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Lin Y; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Ji J; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Chen A; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Beumer JH; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Mehnert JM; Frederick National Lab for Cancer Research, Bethesda, MD, USA.
Cancer Chemother Pharmacol ; 89(1): 49-58, 2022 01.
Article em En | MEDLINE | ID: mdl-34669023
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Benzimidazóis / Protocolos de Quimioterapia Combinada Antineoplásica / Ciclofosfamida / Neoplasias Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Benzimidazóis / Protocolos de Quimioterapia Combinada Antineoplásica / Ciclofosfamida / Neoplasias Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos